Leukocyte subtypes and adverse clinical outcomes in patients with acute ischemic cerebrovascular events.

ABSTRACT:

Background

Our study aimed to evaluate whether the effects on adverse clinical outcomes, defined as death, recurrent stroke, and poor functional outcomes, differed by leukocyte subtype in patients with acute ischemic cerebrovascular events, including both ischemic stroke and transient ischemic attack (TIA).

Methods

We derived data from the Third China National Stroke Registry (CNSR-III). The counts and percentages of each leukocyte subtype were collected within the first 24 hours after admission. Enrolled patients were classified into four groups by the quartiles of each leukocyte subtype count or percentage. Hazard ratios (HRs) or odds ratios (ORs) and their 95% confidence intervals (CIs) of adverse clinical outcomes were calculated, with the lowest quartile group as the re

SUBMITTER: Wang A 

PROVIDER: S-EPMC8246222 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature